EP300 and head and neck squamous cell carcinoma: We utilized shRNA KD to either CREBBP or EP300 in HNSCC cell lines (Fig. 2d and Supplementary Fig. 2) of varying CREBBP/EP300 mutation status (see Supplementary Table 1 for details).